Figure 3From: Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin Results of the quantitative bone cultures showing median values for each treatment group. The difference between BT2-peg2-vancomycin diformate (BTV) every 12 hours (q12 h) and each of the other groups was statistically significant (P ≤ 0.0150). (BTV q12 h 3.5 d, q4 d, treatment twice daily for 3.5 days and then once every 4 days; BTV q1 wk, treatment once per week).Back to article page